Navigation Links
Imaging Modality That Might Help Diagnose Depression

Researchers say they may have found a way to diagnose melancholic depression using an imaging technology that allows them to observe // levels of certain substances in the brain. Melancholia is a relatively common form of depression marked by insomnia, loss of appetite, and loss of pleasure.

Results of the study show low levels of the inhibitory transmitter GABA and high levels of the excitatory neurotransmitter glutamate in the brain appear to be linked to melancholic depression. Researchers say the findings add to mounting evidence that shows, along with serotonin and norepinepherine systems, both the GABA and glutamate systems also contribute to the mechanism and treatment of mood disorders. They feel that this may ultimately help doctors make more accurate diagnoses that could more effectively guide treatment planning.

In the study, 38 healthy individuals and 33 individuals with major depressive disorder participated. It was found that depressed subjects with melancholic features appear to have the largest and most consistent GABA reductions.

Thus researchers say they hope to explore the usefulness of GABA, glutamate, and other biological markers to identify various types of depression and predict specific treatment responses.
'"/>




Page: 1

Related medicine news :

1. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
2. Optical Imaging Added To Ultrasound To Improve Imaging Of Breast Cancer
3. Using Eyes As The Line Of Reference For Fetal Brain Imaging
4. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
5. New Computerized Imaging Systems Help In Better Dental Treatment Planning
6. Magnetic Resonance Imaging Can Now Be Used For Mind Reading
7. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
8. Brain Is More Active While Hiding The Truth, Reveals fMRI Imaging
9. 3-D Imaging For Monitoring Reactor Systems, Power Plants
10. Brian Imaging Can Foretell Results Of Treating Depression
11. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... CO (PRWEB) , ... September 21, 2017 , ... ... Interview of the Month, Lewis and Clark College Emeritus Professor of Education Gregory ... Faith Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and ...
(Date:9/20/2017)... ... September 20, 2017 , ... On ... Best Places to Work in the Research Triangle for 2017. , Winners were ... company had to meet a threshold in employee participation--a percentage that varies based ...
(Date:9/20/2017)... ... September 20, 2017 , ... Mirror Mirror Beauty ... , Look Awesome This Autumn with CoolSculpting®. Scheduled for Thursday, September 28th, the ... , Mirror Mirror Beauty Boutique is Houston’s largest CoolSculpting provider, holding ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is proud ... The Guard®, has helped another long-time client pass their Department of Health and ... the law. , Thanks to the help of the Compliancy Group's Audit Response ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... Five consumer ... innovation and market impact in 27 different categories. Nopavera Plus was named ... category will be announced at SupplySide West 2017 during presentations at SupplySide Central on ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... STOCKHOLM , Sept. 7, 2017 NuvoAir ... Air Smart Spirometer, announced today a partnership with Novartis Pharma ... partnership solidifies NuvoAir,s position as the leading mobile spirometry platform ... respiratory patients. ... spirometry test ...
(Date:9/6/2017)... , Sept. 6, 2017  Robert G. Szewc, ... Pinnacle Professional Member in recognition of his contributions to ... serves as a Nephrologist at the practice of Kidney ... medicine, kidney care and hypertension solutions. He has worked ... years of career experience, as well as expertise in ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: